hepatitis B

Biotech

Roche drops midphase hepatitis B and eye disease programs

Roche has taken the scissors to its pipeline, snipping off phase 2 studies of potential treatments for hepatitis B virus and geographic atrophy.
Nick Paul Taylor Oct 18, 2022 5:55am

Functional cure setback triggers layoffs at Assembly

Jul 21, 2022 9:14am

Antios hep B drug slows viral rebound, but FDA hold casts shadow

Jun 27, 2022 11:41am

GSK talks up hep B functional cure after posting phase 2 data

Jun 27, 2022 5:29am

Antios rocked as hepatitis B safety signal sparks clinical hold

May 25, 2022 8:42am

Finch's nest thins out: 20% of employees cut in restructuring

Apr 19, 2022 10:44am